5 results on '"Raynes, Jeremy M"'
Search Results
2. Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients.
- Author
-
Pilapitiya, Devaki H, Harris, Paul W R, Hanson-Manful, Paulina, McGregor, Reuben, Kowalczyk, Renata, Raynes, Jeremy M, Carlton, Lauren H, Dobson, Renwick C J, Baker, Michael G, Brimble, Margaret, Lukomski, Slawomir, and Moreland, Nicole J
- Subjects
RHEUMATIC fever ,ANTIBODY formation ,AUTOANTIBODIES ,PEPTIDES ,PROTEINS ,IMMUNOGLOBULIN G ,COLLAGEN - Abstract
Acute rheumatic fever (ARF) is a serious post-infectious immune sequelae of Group A streptococcus (GAS). Pathogenesis remains poorly understood, including the events associated with collagen autoantibody generation. GAS express streptococcal collagen-like proteins (Scl) that contain a collagenous domain resembling human collagen. Here, the relationship between antibody reactivity to GAS Scl proteins and human collagen in ARF was investigated. Serum IgG specific for a representative Scl protein (Scl1.1) together with collagen-I and collagen-IV mimetic peptides were quantified in ARF patients (n = 36) and healthy matched controls (n = 36). Reactivity to Scl1.1 was significantly elevated in ARF compared to controls (P < 0.0001) and this was mapped to the collagen-like region of the protein, rather than the N-terminal non-collagenous region. Reactivity to collagen-1 and collagen-IV peptides was also significantly elevated in ARF cases (P < 0.001). However, there was no correlation between Scl1.1 and collagen peptide antibody binding, and hierarchical clustering of ARF cases by IgG reactivity showed two distinct clusters, with Scl1.1 antigens in one and collagen peptides in the other, demonstrating that collagen autoantibodies are not immunologically related to those targeting Scl1.1. Thus, anti-collagen antibodies in ARF appear to be generated as part of the autoreactivity process, independent of any mimicry with GAS collagen-like proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Mapping Autoantibodies in Children With Acute Rheumatic Fever.
- Author
-
McGregor, Reuben, Tay, Mei Lin, Carlton, Lauren H., Hanson-Manful, Paulina, Raynes, Jeremy M., Forsyth, Wasan O., Brewster, Diane T., Middleditch, Martin J., Bennett, Julie, Martin, William John, Wilson, Nigel, Atatoa Carr, Polly, Baker, Michael G., and Moreland, Nicole J.
- Subjects
PROTEIN microarrays ,AUTOANTIBODIES ,RHEUMATIC fever ,MOLECULAR mimicry ,AUTOANTIGENS ,PATHOGENESIS - Abstract
Background: Acute rheumatic fever (ARF) is a serious sequela of Group A Streptococcus (GAS) infection associated with significant global mortality. Pathogenesis remains poorly understood, with the current prevailing hypothesis based on molecular mimicry and the notion that antibodies generated in response to GAS infection cross-react with cardiac proteins such as myosin. Contemporary investigations of the broader autoantibody response in ARF are needed to both inform pathogenesis models and identify new biomarkers for the disease. Methods: This study has utilised a multi-platform approach to profile circulating autoantibodies in ARF. Sera from patients with ARF, matched healthy controls and patients with uncomplicated GAS pharyngitis were initially analysed for autoreactivity using high content protein arrays (Protoarray, 9000 autoantigens), and further explored using a second protein array platform (HuProt Array, 16,000 autoantigens) and 2-D gel electrophoresis of heart tissue combined with mass spectrometry. Selected autoantigens were orthogonally validated using conventional immunoassays with sera from an ARF case-control study (n=79 cases and n=89 matched healthy controls) and a related study of GAS pharyngitis (n=39) conducted in New Zealand. Results: Global analysis of the protein array data showed an increase in total autoantigen reactivity in ARF patients compared with controls, as well as marked heterogeneity in the autoantibody profiles between ARF patients. Autoantigens previously implicated in ARF pathogenesis, such as myosin and collagens were detected, as were novel candidates. Disease pathway analysis revealed several autoantigens within pathways linked to arthritic and myocardial disease. Orthogonal validation of three novel autoantigens (PTPN2, DMD and ANXA6) showed significant elevation of serum antibodies in ARF (p < 0.05), and further highlighted heterogeneity with patients reactive to different combinations of the three antigens. Conclusions: The broad yet heterogenous elevation of autoantibodies observed suggests epitope spreading, and an expansion of the autoantibody repertoire, likely plays a key role in ARF pathogenesis and disease progression. Multiple autoantigens may be needed as diagnostic biomarkers to capture this heterogeneity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Systems immunology reveals a linked IgG3–C4 response in patients with acute rheumatic fever.
- Author
-
Chung, Amy W, Ho, Timothy KC, Hanson‐Manful, Paulina, Tritscheller, Susanne, Raynes, Jeremy M, Whitcombe, Alana L, Tay, Mei Lin, McGregor, Reuben, Lorenz, Natalie, Oliver, Jane R, Gurney, Jason K, Print, Cristin G, Wilson, Nigel J, Martin, William J, Williamson, Deborah A, Baker, Michael G, and Moreland, Nicole J
- Subjects
RHEUMATIC fever ,RHEUMATIC heart disease ,STREPTOCOCCAL diseases ,PATHOLOGY ,IMMUNOLOGY ,COMPLEMENT receptors - Abstract
Acute rheumatic fever (ARF) and chronic rheumatic heart disease (RHD) are autoimmune sequelae of a Group A streptococcal infection with significant global mortality and poorly understood pathogenesis. Immunoglobulin and complement deposition were observed in ARF/RHD valve tissue over 50 years ago, yet contemporary investigations have been lacking. This study applied systems immunology to investigate the relationships between the complement system and immunoglobulin in ARF. Patients were stratified by C‐reactive protein (CRP) concentration into high (≥10 μg mL−1) and low (<10 μg mL−1) groups to distinguish those with clinically significant inflammatory processes from those with abating inflammation. The circulating concentrations of 17 complement factors and six immunoglobulin isotypes and subclasses were measured in ARF patients and highly matched healthy controls using multiplex bead‐based immunoassays. An integrative statistical approach combining feature selection and principal component analysis revealed a linked IgG3–C4 response in ARF patients with high CRP that was absent in controls. Strikingly, both IgG3 and C4 were elevated above clinical reference ranges, suggesting these features are a marker of ARF‐associated inflammation. Humoral immunity in response to M protein, an antigen implicated in ARF pathogenesis, was completely polarized to IgG3 in the patient group. Furthermore, the anti‐M‐protein IgG3 response was correlated with circulating IgG3 concentration, highlighting a potential role for this potent immunoglobulin subclass in disease. In conclusion, a linked IgG3–C4 response appears important in the initial, inflammatory stage of ARF and may have immediate utility as a clinical biomarker given the lack of specific diagnostic tests currently available. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever.
- Author
-
Raynes, Jeremy M., Frost, Hannah R. C., Williamson, Deborah A., Young, Paul G., Baker, Edward N., Steemson, John D., Loh, Jacelyn M., Proft, Thomas, Dunbar, P. R., Atatoa Carr, Polly E., Bell, Anita, and Moreland, Nicole J.
- Subjects
STREPTOCOCCUS ,PATIENTS ,RHEUMATIC fever - Abstract
Acute rheumatic fever (ARF) is an autoimmune response to Group A Streptococcus (GAS) infection. Repeated GAS exposures are proposed to 'prime' the immune system for autoimmunity. This notion of immune-priming by multiple GAS infections was first postulated in the 1960s, but direct experimental evidence to support the hypothesis has been lacking. Here, we present novel methodology, based on antibody responses to GAS T-antigens, that enables previous GAS exposures to be mapped in patient sera. T-antigens are surface expressed, type specific antigens and GAS strains fall into 18 major clades or T-types. A panel of recombinant T-antigens was generated and immunoassays were performed in parallel with serum depletion experiments allowing type-specific T-antigen antibodies to be distinguished from cross-reactive antibodies. At least two distinct GAS exposures were detected in each of the ARF sera tested. Furthermore, no two sera had the same T-antigen reactivity profile suggesting that each patient was exposed to a unique series of GAS T-types prior to developing ARF. The methods have provided much-needed experimental evidence to substantiate the immune-priming hypothesis, and will facilitate further serological profiling studies that explore the multifaceted interactions between GAS and the host. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.